Immunovant Inc Financial Flexibility Index
Immunovant Inc financial flexibility index. Immunovant Inc (IMVT) has a Financial Flexibility Index of -1.06x as of June 2026. Free cash flow of $-124.41 Million (operating CF $-124.41 Million minus capex $0.00) represents -1% of total liabilities ($117.10 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Immunovant Inc (2018–2026)
Financial flexibility index of Immunovant Inc from 2018 to 2026. Historical Financial Flexibility Index trend for Immunovant Inc across 9 annual periods. Check IMVT operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Immunovant Inc Financial Flexibility Index by Year (2018–2026)
Immunovant Inc financial flexibility index by year from 2018 to 2026. Year-by-year free cash flow to debt coverage for Immunovant Inc. For the full cash flow conversion analysis, see IMVT cash generation efficiency.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2026 | -3.88x | $-407.30 Million | $-407.31 Million | $104.97 Million | ▲ +28.9% |
| 2025 | -5.45x | $-375.12 Million | $-375.87 Million | $68.78 Million | ▼ -24.8% |
| 2024 | -4.37x | $-213.87 Million | $-214.23 Million | $48.95 Million | ▼ -0.7% |
| 2023 | -4.34x | $-188.00 Million | $-188.19 Million | $43.34 Million | ▼ -87.4% |
| 2022 | -2.31x | $-105.86 Million | $-106.11 Million | $45.74 Million | ▲ +41.5% |
| 2021 | -3.96x | $-83.12 Million | $-83.33 Million | $21.01 Million | ▼ -13.6% |
| 2020 | -3.48x | $-53.33 Million | $-53.36 Million | $15.32 Million | ▲ +95.4% |
| 2019 | -74.90x | $-28.50 Million | $-28.55 Million | $380.45K | ▲ +6.0% |
| 2018 | -79.66x | $-128.25 Million | $-128.30 Million | $1.61 Million | — |